#CRS&HIPEC, all countries, research, Treatment
Pseudomyxoma peritonei (PMP) is a rare malignant disease characterized by the progressive and multifocal accumulation of abundant mucinous tumour tissue in the peritoneal cavity. It is generally associated with a perforated epithelial neoplasm of the appendix. The...
#Basingstoke, all countries, research
Pseudomyxoma Survivor is supporting exciting new research into the biology of pseudomyxoma peritonei. The study is a collaboration between the Peritoneal Malignancy Institute, Basingstoke, and the Cancer Sciences Unit, University of Southampton. It analyses gene...
#PatientAdvocacy, all countries, research, Volunteering
In December, Susan and Angela have been asked to present at the EuroPMP International Workshop on pseudomyxoma peritonei. It is a privilege to be asked to present to this network of experts from many fields, including surgeons, pathologists, oncologists, radiologists,...
#diagnosis, all countries, research, Treatment
The BMJ defines evidence-based medicine¹ as: “the conscientious, explicit, and judicious use of current best evidence in making decisions about the care of individual patients” It’s a constantly evolving definition and at Pseudomyxoma Survivor, we...
#InTheNews, #RaisingAwareness, all countries, research
The PERITONEAL SURFACE ONCOLOGY GROUP INTERNATIONAL conference (PSOGI2018), now in its 11th year, is almost upon us. I can’t quite believe it’s been two years since we attended the one in Washington DC! PSOGI is a non-profit organisation which aims to...
Recent Comments